2 stories mentioning HKG:0950Updated 1d ago
Every FINWIRES story that references HKG:0950, newest first.
Lee's Pharmaceutical (HKG:0950) said it was launching an up to HK$50 million share buy back, according to a Tuesday filing with the Hong Kong bourse.The company said its current share price does not reflect its intrinsic value, representing a good opportunity to conduct the buyback.Shares of the company jumped nearly 8% in late morning trade Wednesday.
The Gates Foundation selected Lee's Pharmaceutical (HKG:0950) to receive funding for its synthetic surfactant project, according to a Monday filing with the Hong Kong bourse.The pharmaceutical company's shares gained nearly 2% in morning trade Tuesday.The funding will support the development of the active pharmaceutical ingredient and manufacturing processes for the drug.Long term, the project is meant to bring the life-saving medication to low- and middle-income countries to help premature infants suffering from respiratory distress syndrome.
